UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTSUnaudited Pro Forma Condensed Combined Financial Statements • May 18th, 2020 • Sonnet BioTherapeutics Holdings, Inc. • Pharmaceutical preparations
Sonnet BioTherapeutics, Inc. (“Sonnet Sub”) and Sonnet BioTherapeutics Holdings, Inc. (“Sonnet” or the “Company”), formerly known as “Chanticleer Holdings, Inc.”, entered into an Agreement and Plan of Merger dated October 10, 2019 (the “Merger Agreement”), as amended by Amendment No. 1 thereto made and entered into as of February 7, 2020 (the “First Amendment”) (the Merger Agreement, as amended by the First Amendment, the “Amended Merger Agreement”) as approved by the Sonnet stockholders on March 18, 2020, pursuant to which Sonnet Sub became a wholly owned subsidiary of Sonnet (the “Merger”).
